Search Results - "Hung Lo, Kim"

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease by Rennard, Stephen I, Fogarty, Charles, Kelsen, Steven, Long, William, Ramsdell, Joe, Allison, James, Mahler, Donald, Saadeh, Constantine, Siler, Thomas, Snell, Phillip, Korenblat, Phillip, Smith, William, Kaye, Mitchell, Mandel, Michael, Andrews, Charles, Prabhu, Rachakonda, Donohue, James F, Watt, Rosemary, Lo, Kim Hung, Schlenker-Herceg, Rozsa, Barnathan, Elliot S, Murray, John, on behalf of COPD Investigators

“…Chronic obstructive pulmonary disease (COPD) is a progressive, smoking-related, inflammatory lung disease in which tumor necrosis factor-alpha is overexpressed…”
Get full text

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study by Mease, Philip, Elaine Husni, M., Chakravarty, Soumya D., Kafka, Shelly, Parenti, Dennis, Kim, Lilianne, Hung Lo, Kim, Hsia, Elizabeth C., Kavanaugh, Arthur

“…Objective To evaluate whether intravenous (IV) golimumab produces improvements in skin and nail symptoms that are concomitant with improvements in quality of…”
Get full text

Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease: A Novel Method for Assessing Disease Activity by Adler, Jeremy, Colletti, Richard B, Noonan, Lenore, Berzin, Tyler M, Cheifetz, Adam S, Conklin, Laurie S, Hoops, Timothy C, Huang, Christopher S, Lewis, Blair, Mishkin, Daniel S, Hung Lo, Kim, Xiao, Yongling, Volger, Sheri

“…Abstract Background To demonstrate treatment efficacy in Crohn’s disease (CD), regulatory authorities require that trials include an endoscopic…”
Get full text

A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma by WENZEL, Sally E, BARNES, Peter J, BAKER, James, HORVATH, Ildiko, MARK, Zsuzsanna, BERNSTEIN, David, KERWIN, Edward, SCHLENKER-HERCEG, Rozsa, KIM HUNG LO, WATT, Rosemary, BARNATHAN, Elliot S, CHANEZ, Pascal, BLEECKER, Eugene R, BOUSQUET, Jean, BUSSE, William, DAHLEN, Sven-Erik, HOLGATE, Stephen T, MEYERS, Deborah A, RABE, Klaus F, ANTCZAK, Adam

“…The treatment effect of golimumab, a human monoclonal antibody against tumor necrosis factor (TNF)-alpha, in severe persistent asthma is unknown. To assess the…”
Get full text

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe Heart failure: Results of the anti-TNF therapy against congestive Heart failure (ATTACH) trial by CHUNG, Eugene S, PACKER, Milton, KIM HUNG LO, FASANMADE, Adedigbo A, WILLERSON, James T

“…Preclinical and preliminary clinical data have suggested that tumor necrosis factor-alpha (TNFalpha) may play a role in the evolution and progression of heart…”
Get full text

Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement by Baughman, Robert P, Drent, Marjolein, Kavuru, Mani, Judson, Marc A, Costabel, Ulrich, du Bois, Roland, Albera, Carlo, Brutsche, Martin, Davis, Gerald, Donohue, James F, Muller-Quernheim, Joachim, Schlenker-Herceg, Rozsa, Flavin, Susan, Lo, Kim Hung, Oemar, Barry, Barnathan, Elliot S, on behalf of Sarcoidosis Investigators

“…Evidence suggests that tumor necrosis factor (TNF)-alpha plays an important role in the pathophysiology of sarcoidosis. To assess the efficacy of infliximab in…”
Get full text

Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease by Rosh, Joel R, Turner, Dan, Hyams, Jeffrey S, Dubinsky, Marla, Griffiths, Anne M, Cohen, Stanley A, Hung Lo, Kim, Kim, Lilianne, Volger, Sheri, Zhang, Renping, Strauss, Richard, Conklin, Laurie S

“…Abstract Background and Aims Most paediatric inflammatory bowel disease [IBD] studies are performed after medications are approved in adults, and the majority…”
Get full text

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial by Mease, Philip, Husni, M Elaine, Kafka, Shelly, Chakravarty, Soumya D, Harrison, Diane D, Lo, Kim Hung, Xu, Stephen, Hsia, Elizabeth C, Kavanaugh, Arthur

“…In the GO-VIBRANT trial of intravenous golimumab in psoriatic arthritis (PsA), golimumab significantly inhibited radiographic progression. In post hoc…”
Get full text

Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation by Baughman, Robert P, Shipley, Ralph, Desai, Sujal, Drent, Marjolein, Judson, Marc A, Costabel, Ulrich, du Bois, Roland M, Kavuru, Mani, Schlenker-Herceg, Rozsa, Flavin, Susan, Lo, Kim Hung, Barnathan, Elliot S

“…The best method to interpret the chest roentgenogram and its sensitivity to detect effect of treatment for sarcoidosis remains unclear. In a double-blind,…”
Get more information

304 Dysregulated serum cytokines in association with clinical manifestations in patients with systemic lupus erythematosus by Seridi, Loqmane, Leonardo, Stephen, Scott, Brittney, Gordon, Robert M, Shu, Cathye, Fei, Kaiyin, Lo, Kim Hung, Stevens, Anne, Gao, Sheng

“…BackgroundSystemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease affecting multiple organ systems, making clinical trial design challenging…”
Get full text

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study by Deodhar, Atul, Shiff, Natalie J., Gong, Cinty, Chan, Eric K. H., Hsia, Elizabeth C., Lo, Kim Hung, Akawung, Alianu, Kim, Lilianne, Xu, Stephen, Reveille, John D.

“…Introduction We studied the effect of intravenous (IV)-golimumab on fatigue and the association of fatigue improvement with clinical response post hoc in…”
Get full text

The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial by BINGHAM, Clifton O, WEINBLATT, Michael, CHENGLONG HAN, GATHANY, Timothy A, KIM, Lilianne, KIM HUNG LO, BAKER, Dan, MENDELSOHN, Alan, WESTHOVENS, Rene

“…To evaluate the effects of intravenous (IV) golimumab 2 mg/kg + methotrexate (MTX) on patient-reported measures of health-related quality of life (HRQOL) in…”
Get full text

Inflammatory Profile and Response to Anti-Tumor Necrosis Factor Therapy in Patients with Chronic Pulmonary Sarcoidosis by Loza, Matthew J, Brodmerkel, Carrie, Du Bois, Roland M, Judson, Marc A, Costabel, Ulrich, Drent, Marjolein, Kavuru, Mani, Flavin, Susan, Lo, Kim Hung, Barnathan, Elliot S, Baughman, Robert P

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus by Vollenhoven, Ronald F., Hahn, Bevra H., Tsokos, George C., Lipsky, Peter, Fei, Kaiyin, Gordon, Robert M., Gregan, Irene, Lo, Kim Hung, Chevrier, Marc, Rose, Shawn

“…Objective To evaluate the efficacy and safety of ustekinumab through 1 year in a phase II trial in patients with systemic lupus erythematosus (SLE). Methods…”
Get full text

Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis: Results Through Week Twenty-Four of the GO-VIBRANT Study by Kavanaugh, Arthur, Husni, M Elaine, Harrison, Diane D, Kim, Lilianne, Lo, Kim Hung, Leu, Jocelyn H, Hsia, Elizabeth C

“…To evaluate the safety and efficacy of intravenous (IV) golimumab treatment in psoriatic arthritis (PsA). In this phase III, randomized, double-blind,…”
Get full text

VALIDATION OF THE SIMPLIFIED ENDOSCOPIC MUCOSAL ASSESSMENT OF CROHN’S DISEASE (SEMA-CD) A NOVEL ENDPOINT TO ASSESS ENDOSCOPIC IMPROVEMENT WITH REAL WORLD DATA by Adler, Jeremy, Colletti, Richard, Noonan, Lenore, Conklin, Laurie, Lo, Kim Hung, Xiao, Yongling, Volger, Sheri

Get full text

VALIDATION OF THE SIMPLIFIED ENDOSCOPIC MUCOSAL ASSESSMENT OF CROHN’S DISEASE (SEMA-CD) A NOVEL ENDPOINT TO ASSESS ENDOSCOPIC IMPROVEMENT WITH REAL WORLD DATA by Adler, Jeremy, Colletti, Richard, Noonan, Lenore, Conklin, Laurie, Lo, Kim Hung, Xiao, Yongling, Volger, Sheri

Get full text

Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study by Deodhar, Atul, Reveille, John D, Harrison, Diane D, Kim, Lilianne, Lo, Kim Hung, Leu, Jocelyn H, Hsia, Elizabeth C

“…To evaluate the safety and efficacy of intravenous golimumab (GOL) in patients with active ankylosing spondylitis (AS). In a phase III, randomized,…”
Get full text

Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study by van Vollenhoven, Ronald F, Hahn, Bevra H, Tsokos, George C, Lipsky, Peter, Gordon, Robert M, Fei, Kaiyin, Lo, Kim Hung, Chevrier, Marc, Rose, Shawn, Berry, Pamela, Yao, Zhenling, Karyekar, Chetan S, Zuraw, Qing

“…To evaluate the long-term efficacy and safety of ustekinumab through 2 years in patients with active systemic lupus erythematosus (SLE). This was a…”
Get full text

Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study by Reveille, John D, Deodhar, Atul, Caldron, Paul H, Dudek, Anna, Harrison, Diane D, Kim, Lilianne, Lo, Kim Hung, Leu, Jocelyn H, Hsia, Elizabeth C

“…Evaluate safety and efficacy of intravenous (IV) golimumab (GOL) in patients with active ankylosing spondylitis (AS) through 1 year. A total of 208 patients…”
Get full text